Robert Landry

Robert Landry

Director of Finance/CFO at CHECKMATE PHARMACEUTICALS, INC.

Net worth: 23 M $ as of 2024-02-28

60 year
Health Technology
Consumer Services

Profile

Robert E. Landry is Chief Financial Officer & Executive VP-Finance at Regeneron Pharmaceuticals, Inc. He previously was Treasurer & Senior Vice President at Pfizer Inc. Director-Pharmaceutical Marketing & Sales at Wyeth Australia Pty Ltd. Chief Financial Officer of Wyeth New Zealand and Treasurer & Principal Corporate Officer at Wyeth Corp. (which are all subsidiaries of Pfizer Inc.). Mr. Landry received an undergraduate degree from the University of Notre Dame.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-01 23,963 ( 0.02% ) 23 M $ 2024-02-28

Robert Landry active positions

CompaniesPositionStart
CHECKMATE PHARMACEUTICALS, INC. Director of Finance/CFO 2022-05-30
DECIBEL THERAPEUTICS, INC. Director of Finance/CFO 2023-09-21
All active positions of Robert Landry

Former positions of Robert Landry

CompaniesPositionEnd
REGENERON PHARMACEUTICALS, INC. Director of Finance/CFO 2024-02-04
PFIZER, INC. Corporate Officer/Principal 2012-09-30
Treasurer 2009-09-30
Wyeth Australia Pty Ltd. Director of Finance/CFO 2005-12-31
Wyeth New Zealand Director of Finance/CFO 2005-12-31
See the detail of Robert Landry's experience

Training of Robert Landry

University of Notre Dame Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert Landry's experience

Connections

97

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
PFIZER, INC.

Health Technology

REGENERON PHARMACEUTICALS, INC.

Health Technology

DECIBEL THERAPEUTICS, INC.

Health Technology

Private companies4

Health Technology

Wyeth Australia Pty Ltd.

Wyeth New Zealand

Health Technology

See company connections
  1. Stock
  2. Insiders
  3. Robert Landry